GC Wealth Management RIA’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,206
Closed -$1.18M 594
2025
Q3
$1.18M Buy
6,206
+4,674
+305% +$829K 0.04% 287
2025
Q2
$275K Buy
+1,532
New +$266K 0.02% 456

Other funds holding DGX

GC Wealth Management RIA's DGX Position: Q4 2025 in Review

GC Wealth Management RIA sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 6,206 shares — an estimated $1.18M sold.

GC Wealth Management RIA first reported a position in DGX in Q2 2025 and held it in 2 quarters. The position peaked at $1.18M in Q3 2025. 1,048 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • GC Wealth Management RIA reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
  • GC Wealth Management RIA sold 6,206 Quest Diagnostics shares in Q4 2025, an estimated $1.18M.
  • GC Wealth Management RIA first reported a position in Quest Diagnostics in Q2 2025 and held it in 2 quarters.
  • GC Wealth Management RIA's Quest Diagnostics position peaked at $1.18M in Q3 2025.
  • 1,048 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on GC Wealth Management RIA's 13F filing for Q4 2025, filed 30 Jan 2026.